结节病性葡萄膜炎眼部复发及视力预后的相关因素
这项多中心回顾性队列研究纳入336例结节病性葡萄膜炎患者,中位随访7.8年。结果显示66.7%的患者出现眼部复发,中位复发时间2.6年,基线黄斑水肿和持续炎症与较短的无复发生存期相关;随访结束时约6.5%的患者存在视力损害,约0.9%失明。
要点
- 结节病性葡萄膜炎患者中约三分之二出现眼部复发,中位复发时间2.6年。
- 基线黄斑水肿(HR 1.47)和持续炎症(HR 1.68)与较短的无复发生存期相关。
- 随访结束时约6.5%存在视力损害,约0.9%失明;因事件数少无法估计视力损害风险因素。
核心结论
- 结节病性葡萄膜炎约三分之二患者复发,复发与基线黄斑水肿和持续炎症相关。
- 多数患者保持足够可用视力,约6%出现轻、中或重度视力损害,约1%失明(中位随访7.8年)。
研究设计与样本
- 多中心回顾性队列研究,纳入336例结节病性葡萄膜炎患者,其中208例(61.9%)为女性,葡萄膜炎诊断时中位年龄52岁(范围10-89岁)。
- 记录整个随访期间的眼部复发和新发视力损害,采用Kaplan-Meier曲线和Cox比例风险模型分析相关因素,统计学显著性设为P < 0.05。
主要发现
- 中位随访7.8年,279例(83.0%)患者结节病经组织学证实。
- 224例(66.7%)患者出现眼部复发,中位复发时间2.6年(四分位距1.6-4.4)。
- 基线存在黄斑水肿(HR 1.47,95%CI 1.07-2.02,P = 0.020)和持续炎症(HR 1.68,95%CI 1.17-2.40,P = 0.004)与较短的无复发生存期相关。
- 随访结束时,325例中21例(6.5%)存在视力损害:轻度12/325(3.7%)、中度6/325(1.9%)、重度0/325(0.0%),盲3/325(0.9%)。
- 视力损害主要原因:青光眼9/20(45.0%)、黄斑水肿8/20(40.0%)、视网膜前膜6/20(30.0%)。
局限性
- 因事件数少,无法估计较短的无视力损害生存期的风险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To describe the factors associated with ocular relapse and visual prognosis in patients with sarcoid uveitis. DESIGN: Multicentric, retrospective cohort study. PARTICIPANTS: A total of 336 patients were included, of whom 208 (61.9%) were female. Median age at uveitis diagnosis was 52 years (range, 10-89 years). METHODS: Ocular relapses and incident visual impairment were recorded over the entire duration of follow-up. Factors associated with ocular relapses and visual impairment were subsequently analyzed. Kaplan-Meier curves for ocular relapse-free survival (RFS) and visual impairment-free survival were constructed for selected variables. Cox proportional hazards model was then applied to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Statistical significance was set at the P < 0.05 level. MAIN OUTCOME MEASURES: Time to ocular relapse and time to visual impairment. RESULTS: Median follow-up was 7.8 years. Sarcoidosis was histologically proven in 279 patients (83.0%). Ocular relapses occurred in 224 patients (66.7%). The median time to ocular relapse was 2.6 years (interquartile range, 1.6-4.4). Shorter ocular RFS was associated with the presence of macular edema (HR, 1.47, 95% CI, 1.07-2.02, P = 0.020) and persistent inflammation (HR, 1.68, 95% CI, 1.17-2.40, P = 0.004) at baseline. According to World Health Organization definitions, visual impairment was present in 21 of 325 patients (6.5%) at the end of follow-up. Visual impairment was mild in 12 of 325 patients (3.7%), moderate in 6 of 325 patients (1.9%), and severe in 0 of 325 patients (0.0%), and 3 of 325 patients (0.9%) were blind. The main causes of visual impairment were glaucoma in 9 of 20 patients (45.0%), macular edema in 8 of 20 patients (40.0%), and epiretinal membrane in 6 of 20 patients (30.0%). Risk factors for shorter visual impairment-free survival could not be estimated because of the small number of events. CONCLUSIONS: Sarcoid uveitis relapses in approximately two-thirds of patients, and relapses are associated with the presence of macular edema and persistent inflammation at baseline. Most patients with sarcoid uveitis maintain adequate usable vision, with approximately 6% becoming mildly, moderately, or severely visually impaired, and approximately 1% becoming blind after a median follow-up of 7.8 years. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
引用
- Abramowicz S, Jacquot R, Siriphanh A, et al. Factors Associated with Ocular Relapse and Visual Prognosis in Sarcoid Uveitis. Ophthalmology. 2025. PMID: 41177360. doi:10.1016/j.ophtha.2025.10.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。